Sign in

CIK 0001739174 · Non-accelerated filer<br>Smaller reporting company

Tessera Defense & Homeland Security Inc.

Sign in to watch
Ticker
HLSQ
Exchange
NYSE
Industry
Services-Prepackaged Software
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
823364020
Phone
972 545610935
Business address
850 NEW BURTON ROAD, SUITE 201, DOVER, DE, 19904
Former names
BiomX Inc., Chardan Healthcare Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 32 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-10-29 Oron Assaf Chief Business Officer Returned to the company · Common Stock Options - Right to Buy −82,667 0
2023-10-29 Oron Assaf Chief Business Officer Grant or award · Common Stock Options - Right to Buy +82,667 0
2023-10-29 Oron Assaf Chief Business Officer Returned to the company · Common Stock Options - Right to Buy −46,966 0
2023-10-29 Oron Assaf Chief Business Officer Grant or award · Common Stock Options - Right to Buy +46,966 0
2023-10-19 Williams Eddie Director Grant or award · Common Stock Options - Right to Buy +41,000 41,000
2023-08-21 Marks Jason M. Director Grant or award · Common Stock Options - Right to Buy +41,000 41,000
2023-08-21 Dambach Michael E. Director Grant or award · Common Stock Options - Right to Buy +41,000 41,000
2023-05-22 Oron Assaf Chief Business Officer Purchase +3,192 $0.27 $872 10,914
2023-05-19 Oron Assaf Chief Business Officer Purchase +6,521 $0.28 $2K 7,722
2023-05-18 Oron Assaf Chief Business Officer Purchase +1,201 $0.27 $328 1,201
2023-03-01 Greig Russell Director Grant or award · Common Stock Options - Right to Buy +82,000 82,000
2023-03-01 Moses Alan Charles Director Grant or award · Common Stock Options - Right to Buy +41,000 41,000
2023-03-01 Bassan Merav Chief Development Officer Grant or award · Common Stock Options - Right to Buy +100,000 100,000
2023-03-01 Wolfson Marina Chief Financial Officer Grant or award · Common Stock Options - Right to Buy +100,000 100,000
2023-03-01 Sullivan Lynne Marie Director Grant or award · Common Stock Options - Right to Buy +41,000 41,000
2023-03-01 Solomon Jonathan Eitan Chief Executive Officer Grant or award · Common Stock Options - Right to Buy +410,000 410,000
2023-03-01 Oron Assaf Chief Business Officer Grant or award · Common Stock Options - Right to Buy +50,000 50,000
2023-02-27 OrbiMed Israel BioFund GP Limited Partnership 10% owner Purchase +348,000 $0.25 $85K 3,161,489
2023-02-27 OrbiMed Israel BioFund GP Limited Partnership 10% owner Purchase · Warrants (Right to Buy) +1,789,959 1,789,959
2022-11-04 Ugwumba Chidozie Exit Form 4 - former 10% owner Sale −1,501 $0.38 $567 2,997,025

Page 7 of 12 · 240 trades